Click the tags above for all related articles
Scott Gottlieb worked for the FDA during the first phase of the COVID-19 outbreak and later moved to the board of directors of Pfizer. Now he finally admits that the highest risk Gain-of-Function research is being outsourced to the worst labs around the world.